SynthesisOncotarget2017

Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review.

Jung Han Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.